Toxic reaction of memantine in neonatal rats after repetitive administration

Chinese Journal of Clinical Rehabilitation

Volumn 9, Issue 47, 2005, Pages 107-109

  Gao, Ying ^a,b   Chen, Hui Jin ^a   Qian, Long Hua ^a   Jiang, Ming Hua ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMANTINE;

ANIMAL EXPERIMENT; ARTICLE; BODY MASS; BRAIN HYPOXIA; BRAIN ISCHEMIA; CHINA; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG WITHDRAWAL; GROWTH INHIBITION; MORTALITY; NEUROPROTECTION; NEWBORN; NONHUMAN; RAT; RAT STRAIN; SURVIVAL RATE;

EID: 31644440583     PISSN: 16715926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Geter-Donglass B, Witkin JM. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology (Berl) 1999;146 (3):280-9
2. Chinese source. 2001,17(1):72-6
3. Chinese source. 2001,4 (3):163-6
4. Chinese source. 2003,18(10):793-5
5. Chen H, Liu Z, Zhou Z, et al.The regulatory effect of memantine on expression and synthesis of heat shock protein 70 gene in neonatal rat models with cerebral hypoxic ischemia.Chin Med J (Engl) 2003;116(4):558-64
6. Chinese source. 1994:37
7. Gorgulu A, Kins T, Cobanoglu S, et al. Reduction of edema and infraction by Memantine and MK-801 after focal cerebral ischaemia and reperfusion in rat. Acta Neurochir (Wien) 2000;142(11):1287-92
8. Frankiewicz T, Pilc A, Parsons CG, et al.Differential effects of NMDA-receptor antagonists on long-term potentitation and hypoxia/hypoglycemic excitotoxicity in hippocampal slices. Neuropharmacology 2000;39:631-42
9. Chen HS, Wang YF, Rayudu PV, et al.Neuroprotective concentrations of the NMDA open-channel blocker memantine are effective without cytoplasmic vaculation following post-ischemic administration and do not block maze learning or long-term potentiation. Neuroscience 1998;86:1121-32
10. Lipton SA,Chen HS.Paradigm shift in neuroprotective drug development: clinicallt tolerated NMDA receptor inhibition by memantine.Cell Death and Differenttiation 2004;11(1):18-20
11. Hesselink MB, De Boer AG, Breimer DD, et al.Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists. J Neural Transm 1999;106:409-21
12. Olney JW,Labruyere J,Wang G,et al.NMDA antagonist neurotoxicity: mechanism and prevention. Science 1991;254:1515-8